PRF Technologies (PRFX) Non Operating Income (2020 - 2024)
PRF Technologies (PRFX) recorded quarterly Non Operating Income of -$23000.0 in Q2 2024, down 138.98% on a QoQ basis from $59000.0 in Q1 2024, and down 132.39% year-over-year from $71000.0 in Q3 2023.
PRF Technologies (PRFX) Non Operating Income (2020 - 2024) Analysis & Trends
PRF Technologies has disclosed Non Operating Income across 5 years of filings, most recently posting -$23000.0 for Q2 2024.
- Quarterly Non Operating Income fell 132.39% year-over-year to -$23000.0 in Q2 2024, while the trailing twelve-month figure through Jun 2024 was $105000.0 (down 60.38% YoY) and the FY2025 annual result came in at $108000.0, up 200.0% from the prior year.
- Non Operating Income fell to -$23000.0 in Q2 2024, from $59000.0 in the prior quarter.
- Over five years, Non Operating Income peaked at $1.4 million in Q3 2023 and troughed at -$1.3 million in Q4 2023.
- A 5-year average of -$46500.0 and a median of -$2500.0 in 2021 frame the typical range for Non Operating Income.
- Biggest YoY gain for Non Operating Income was 10776.92% in 2023; the steepest drop was 1432.32% in 2023.
- Tracing PRFX's Non Operating Income over 5 years: stood at $897000.0 in 2020, then tumbled by 98.44% to $14000.0 in 2021, then jumped by 607.14% to $99000.0 in 2022, then sank by 1432.32% to -$1.3 million in 2023, then jumped by 98.26% to -$23000.0 in 2024.
- Business Quant data shows PRFX's Non Operating Income at -$23000.0 in Q2 2024, $59000.0 in Q1 2024, and -$1.3 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -216.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 20.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -7.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -504,111.66 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 53.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -13.65 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -23.23 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 5.71 Mn |
| 10 | PRF Technologies | 933,081.16 | -2.46 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -23,000.00 |
| Mar 31, 2024 | 59,000.00 |
| Dec 31, 2023 | -1.32 Mn |
| Sep 30, 2023 | 1.39 Mn |
| Jun 30, 2023 | 71,000.00 |
| Mar 31, 2023 | 108,000.00 |
| Dec 31, 2022 | 99,000.00 |
| Sep 30, 2022 | -13,000.00 |
| Jun 30, 2022 | 22,000.00 |
| Mar 31, 2022 | -22,000.00 |
| Dec 31, 2021 | 14,000.00 |
| Sep 30, 2021 | -3,000.00 |
| Jun 30, 2021 | -41,000.00 |
| Mar 31, 2021 | -2,000.00 |
| Dec 31, 2020 | 897,000.00 |
| Sep 30, 2020 | -389,000.00 |
| Jun 30, 2020 | -519,000.00 |
| Mar 31, 2020 | -1.16 Mn |